S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OTLK Outlook Therapeutics Inc

7.37

-0.14 (-1.86%)

Jun 28 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics Inc News

Form PRE 14A - Other preliminary proxy statements
Friday 14 June 2024 (2 weeks ago) • Edgar (US Regulatory)

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
Tuesday 11 June 2024 (3 weeks ago) • GlobeNewswire Inc.

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Tuesday 28 May 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 15 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (1 month ago) • Edgar (US Regulatory)

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
Wednesday 15 May 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 May 2024 (2 months ago) • Edgar (US Regulatory)

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
Monday 13 May 2024 (2 months ago) • GlobeNewswire Inc.

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
Thursday 9 May 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Monday 6 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 6 May 2024 (2 months ago) • Edgar (US Regulatory)

Outlook Therapeutics® to Present at the Retina World Congress 2024
Thursday 2 May 2024 (2 months ago) • GlobeNewswire Inc.

More Outlook Therapeutics Inc News Articles

Emergent Health (PK)

1812 Brewing (PK)

Global Developments (PK)

Clean Vision (QB)

Asia Broadband (PK)

Ethema Health (PK)

ERHC Energy (CE)

Cann American (CE)

Branded Legacy (PK)

Kraig Biocraft Laborator... (QB)

Ubiquitech Software (PK)

New Momentum (PK)

Decentral Life (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions